Biologic API CDMO Benchmarking (10th Ed.)

Report Overview

ISR’s Biologic API CDMO Benchmarking (10th Edition) report has a wealth of information, created with two goals in mind: (1) Help biopharmaceutical companies make more informed CDMO selection decisions, and (2) Help CDMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CDMO service quality across a series of 23 performance attributes specific to outsourced drug substance manufacturing. In this Consumer Reports-style analysis, ISR presents data on 412 service encounters from 147 respondents who have been involved in outsourced biologic API projects in the past 18 months.

What you will learn:

Drug Developers:

• Uncover which CDMO attributes drive outsourcing partner selection for outsourced bioprocessing as well as which CDMO attributes have gained importance over the past 12 months among industry peers
• Gain insight into CDMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience
• Make a more educated purchase of CDMO services by understanding which manufacturers best fit your company’s needs in addition to how individual CDMOs have measured up to sponsor-peer expectations on similar projects

Contract Manufacturers:

• Compare your company’s performance against its competitors across 23 metrics specific to outsourced bioprocessing
• Gain insight into drug developers’ outsourcing preferences and practices when it comes to CDMO selection and CDMO preference for outsourced biologic API manufacturing
• Understand your company’s competitive position as well as its delivery strengths and weaknesses, then use the information to develop targeted messaging on true areas of strength

Major Sections:

• Outsourcing Philosophies & Practices
• CDMO Selection Drivers
• CDMO Perceptions & Interactions
• CDMO Performance & Loyalty
• The Biologic API CDMO Competitive Landscape
• Company Service Quality Profiles
• Appendix
• CDMO Drill-Downs
• Demographics

Included Providers:

• AbbVie Contract Manufacturing
• Abzena
• AGC Biologics
• Ajinomoto Bio-Pharma Services
• Avid Bioservices
• Axplora
• Bionova
• Boehringer Ingelheim BioXcellence
• Bora Pharmaceuticals
• Catalent
• Celonic
• Curia
• Cytovance Biologics
• FujiFilm Diosynth Biotechnologies
• Genscript ProBio
• Global Biotech Cooperations
• GSK Contract Manufacturing
• Hetero Biopharma
• IDT Biologika
• Just – Evotec Biologics
• KBI Biopharma
• Lonza
• MilliporeSigma
• Olon
• Patheon, by Thermo Fisher Scientific
• Pfizer CentreOne
• Rentschler
• Resilience
• Samsung Biologics
• Sandoz
• Scorpius Biomanufacturing
• Syngene
• Wockhardt
• WuXi Biologics

Companies listed in bold print have been reviewed by 10 or more respondents. These providers have detailed company service quality profiles and are included in an in-depth performance analysis.